Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study
暂无分享,去创建一个
K. Izutsu | T. Chou | H. Shibayama | G. Yamamoto | N. Fukuhara | K. Shibuya | H. Tsujimura | T. Yanai